The following table describes the data elements displayed in the CTRO Daily Override Flag report for each trial:
| Data Element | Description |
|---|---|
| NCI ID | Identifier assigned to this trial by the CTRP. |
| DCP ID | Identifier assigned to this trial by the DCP (Division of Cancer Prevention). For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. |
| CTEP ID | Identifier assigned to this trial by the CTEP (Cancer Therapy Evaluation Program). For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. |
| Lead Organization | Name of the principal administrative organization responsible for this trial's research protocol. For more information, refer to Abstracting Sponsors and Responsible Parties. |
| Sponsor | Name of the primary organization that oversees implementation of study and is responsible for data analysis. For more information, refer to Abstracting Sponsors and Responsible Parties. |
| Send trial information to Clinical | Value indicating whether the system sends the trial information to ClinicalTrials.gov in the automated nightly batch updates (via FTP):
For more information, refer to Abstracting NCI-Specific Information. |
| Completion Date | Date on which final data was collected for the trial, or the date on which that is expected to happen. For more information, refer to Abstracting Trial Statuses. |
| Processing Status | Value indicating the current processing status of the trial. For more information, refer to Abstracting Trial Statuses and Trial Processing Statuses in the CTRP. |
| Current trial status | Current stage or state of a clinical trial or study relative to other stages and its ability to enroll participants/patients. For more information, refer to Abstracting Trial Statuses and Trial Status Values in the CTRP and ClinicalTrials.gov. |
| Primary Completion Date | Date on which the final subject was examined or received an intervention, or the date on which that is expected to happen. For more information, refer to Abstracting Trial Statuses. |
| Primary Completion Type | Value indicating whether the completion date is the one on which the trial is expected to complete (Anticipated), or the date on which it actually completed (Actual). For more information, refer to Abstracting Trial Statuses. |
| Section 801 Indicator | Value indicating whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801. For more information, refer to Abstracting Regulatory Information. |
| Processing Comments | Any comments that an abstractor has recorded for this trial, on the Trial Identification page or Dashboard Details page. For more information, refer to Tracking and Managing Trial Records. |
| CTRO Override Flag Comments | Any comments that an abstractor has recorded (with the "Send Trial Information to ClinicalTrials.gov?" value) for this trial. For more information, refer to Abstracting NCI-Specific Information. |
